Detalles de la búsqueda
1.
Single- and multiple-dose pharmacokinetics and safety of pimodivir, a novel, non-nucleoside polymerase basic protein 2 subunit inhibitor of the influenza A virus polymerase complex, and interaction with oseltamivir: a Phase 1 open-label study in healthy volunteers.
Br J Clin Pharmacol
; 84(11): 2663-2672, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30098042
Resultados
1 -
1
de 1
1
Próxima >
>>